Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

Clinical trial NCT02104830 · COMPLETED

Trial details

NCT number: NCT02104830
Sponsor: Biocad
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-induced Neutropenia

Start date: 2013-09-01
Primary completion: 2014-06-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.